Holen Sie sich die Stockscreener-App
264.49
0.19%
-0.51
Schlusskurs vom Vortag:
$265.00
Offen:
$267.43
24-Stunden-Volumen:
462.44K
Relative Volume:
1.80
Marktkapitalisierung:
$7.14B
Einnahmen:
$2.58B
Nettoeinkommen (Verlust:
$759.90M
KGV:
9.4742
EPS:
27.9168
Netto-Cashflow:
$374.60M
1W Leistung:
+0.64%
1M Leistung:
-2.51%
6M Leistung:
-6.89%
1J Leistung:
+3.94%
1-Tages-Spanne:
$262.05
$267.73
1-Wochen-Bereich:
$258.95
$272.40
52-Wochen-Spanne:
$211.43
$343.12
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Firmenname
Bio Rad Laboratories Inc
Sektor
Branche
Telefon
(510) 724-7000
Adresse
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
264.49 | 7.14B | 2.58B | 759.90M | 374.60M | 27.92 |
ABT
Abbott Laboratories
|
105.46 | 183.26B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
335.67 | 128.46B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.16 | 110.62B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.48 | 103.10B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.50 | 47.92B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-12-07 | Eingeleitet | UBS | Buy |
| 2023-06-16 | Eingeleitet | Wells Fargo | Overweight |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-01-28 | Bestätigt | Citigroup | Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2018-10-17 | Eingeleitet | Goldman | Buy |
| 2018-09-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Herabstufung | CL King | Buy → Neutral |
| 2017-07-13 | Eingeleitet | Wells Fargo | Outperform |
| 2017-06-28 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Eingeleitet | Deutsche Bank | Hold |
| 2016-10-13 | Eingeleitet | CL King | Buy |
| 2015-05-06 | Bestätigt | Jefferies | Buy |
| 2009-12-18 | Eingeleitet | Maxim Group | Buy |
| 2009-11-06 | Eingeleitet | Jefferies & Co | Buy |
| 2009-07-17 | Eingeleitet | Soleil | Buy |
| 2007-09-26 | Eingeleitet | Banc of America Sec | Buy |
| 2007-02-23 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten
Retail Trends: What is the long term forecast for Bio Rad Laboratories Inc. stock2026 Breakouts & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Stock List: Research Stocks from Around the World - GuruFocus
Bio-Rad Laboratories Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo
Disappointing Results Hurt Bio-Rad Laboratories (BIO) - Insider Monkey
ELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape - GlobeNewswire Inc.
Moving Averages: Is Bio Rad Laboratories Inc likely to announce a buybackWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Capillary Electrophoresis Market size to hit $632.8 Million - openPR.com
Bio-Rad Laboratories Inc (BIO) Stock Price Up 3.06% on Mar 17 - GuruFocus
Discipline and Rules-Based Execution in BIO Response - Stock Traders Daily
Moore Capital Management LP Acquires Shares of 55,000 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Gotham Asset Management LLC Acquires 36,763 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Hound Partners LLC Has $29.15 Million Stake in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Mangrove Partners IM LLC Invests $35.57 Million in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Perbak Capital Partners LLP Purchases 5,423 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Portolan Capital Management LLC Has $13.02 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
10,425 Shares in Bio-Rad Laboratories, Inc. $BIO Purchased by Magnetar Financial LLC - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Purchased by Natixis Advisors LLC - MarketBeat
Capital Research Global Investors Makes New Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Assessing Whether Bio-Rad Laboratories (BIO) Looks Undervalued After Recent Share Price Softness - Yahoo Finance
Bio-Rad Laboratories Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Chipmakers Recap: Is Bio Rad Laboratories Inc stock forming a triangle patternJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Dimensional Fund Advisors LP Purchases 63,370 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Published on: 2026-03-07 12:19:08 - baoquankhu1.vn
Bio-Rad outlines flat to 1% currency-neutral revenue growth for 2025 while expanding ddPCR partnerships - MSN
BIO Should I Buy - Intellectia AI
TD Asset Management Inc Purchases 7,386 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories, Inc. $BIO Shares Bought by GW&K Investment Management LLC - MarketBeat
Portfolio Shifts: Will Bio Rad Laboratories Inc outperform its industry peersQuarterly Risk Review & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Teachers Retirement System of The State of Kentucky Has $10.22 Million Stake in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Analysts Issue Forecasts for BIO FY2028 Earnings - MarketBeat
Medical Dry Fluorescence Immunoassay Analyzer Market Is Going - openPR.com
Automatic Blood Group Diagnostic Instrument Market Is Going - openPR.com
Assessing Bio-Rad (BIO) Valuation After Mixed Share Price Performance And Recurring Revenue Shift - simplywall.st
Roubaix Capital LLC Buys Shares of 8,112 Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Zacks Research Has Bearish Estimate for BIO Q1 Earnings - MarketBeat
Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 16.36% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Digital PCR Market to Reach US$ 14.37 Billion by 2033 at 9.8% CAGR; - openPR.com
Artisan Partners Limited Partnership Has $24.22 Million Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Westfield Capital Management Co. LP Increases Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Is It Time To Reconsider Bio-Rad Laboratories (BIO) After Its Prolonged Share Price Slump - Sahm
Bio-Rad Laboratories, Inc. $BIO Shares Sold by Vanguard Group Inc. - MarketBeat
A Look At Bio Rad Laboratories (BIO) Valuation After Recent Share Price Weakness - simplywall.st
(BIO) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Molecular Biology Analyzers Market Set to Boom by 2033: - openPR.com
Microfluidics Research Report 2026-2035: A $20.73 Billion - GlobeNewswire
Microfluidics Research Report 2026-2035: A $20.73 Billion Market by 2030 with Thermo Fisher Scientific, PerkinElmer, Dolomite, Agilent Technologies, Bio-Rad Laboratories, and Fluidigm Leading - Yahoo Finance
Bio-Rad Laboratories (NYSE:BIO.B) Shares Pass Below 200-Day Moving AverageTime to Sell? - MarketBeat
Weekly Earnings: What is the long term forecast for Bio Rad Laboratories Inc stockJuly 2025 Reactions & High Win Rate Trade Alerts - baoquankhu1.vn
International Markets and Bio-Rad (BIO): A Deep Dive for Investors - Yahoo Finance
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.19%
0.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):